We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVPH
1951
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$201K ﹤0.01%
+1,955
New +$175K
CIFRW
1952
CALL
DELISTED
Cipher Mining Warrant
CIFRW
$201K ﹤0.01%
48,720
CRSP icon
1953
CRISPR Therapeutics
CRSP
$4.65B
$200K ﹤0.01%
3,200
-132,747
-98% -$7.34M
INVX
1954
Innovex International
INVX
$1.85B
$200K ﹤0.01%
8,597
-9,664
-53% -$227K
LUXH
1955
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
$200K ﹤0.01%
+478
New +$156K
ARC
1956
DELISTED
ARC Document Solutions, Inc.
ARC
$196K ﹤0.01%
59,852
+24,965
+72% +$73.2K
RPTX
1957
DELISTED
Repare Therapeutics
RPTX
$196K ﹤0.01%
+26,866
New +$150K
SYRS
1958
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$193K ﹤0.01%
+24,818
New +$85K
NVNIW
1959
CALL
Nvni Group Limited Warrants
NVNIW
$578K
$193K ﹤0.01%
+131,040
New +$7.27K
TG icon
1960
Tredegar Corp
TG
$256M
$192K ﹤0.01%
35,467
-22,873
-39% -$113K
EMBJ
1961
Embraer S.A. ADS
EMBJ
$12.1B
$190K ﹤0.01%
+10,300
New +$165K
BKKT icon
1962
Bakkt Inc
BKKT
$338M
$188K ﹤0.01%
+3,376
New +$117K
EBS icon
1963
Emergent Biosolutions
EBS
$382M
$188K ﹤0.01%
78,178
-81,602
-51% -$192K
UPLD icon
1964
Upland Software
UPLD
$12.3M
$187K ﹤0.01%
+4,415
New +$191K
PLGO
1965
Pelagos Insurance Capital
PLGO
$2.22B
$186K ﹤0.01%
14,714
-65,067
-82% -$874K
FRST icon
1966
Primis Financial Corp
FRST
$392M
$184K ﹤0.01%
+14,550
New +$142K
NAAS
1967
NaaS Technology Inc
NAAS
$39.3M
$183K ﹤0.01%
+377
New +$307K
NTST
1968
NETSTREIT Corp
NTST
$2.14B
$180K ﹤0.01%
+10,065
New +$158K
QUAD icon
1969
Quad
QUAD
$441M
$178K ﹤0.01%
32,842
-123,270
-79% -$602K
VMD icon
1970
Viemed Healthcare
VMD
$465M
$177K ﹤0.01%
22,574
+4,974
+28% +$36.1K
FREE
1971
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$175K ﹤0.01%
51,300
-25,600
-33% -$86.4K
SWIM icon
1972
Latham Group
SWIM
$656M
$175K ﹤0.01%
66,400
+19,517
+42% +$48.3K
HD icon
1973
Home Depot
HD
$335B
$173K ﹤0.01%
500
+400
+400% +$124K
ALXO icon
1974
ALX Oncology
ALXO
$277M
$172K ﹤0.01%
+11,569
New +$110K
ZGN icon
1975
Zegna
ZGN
$4B
$172K ﹤0.01%
+14,856
New +$177K

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.